(Q44124066)

30 November 2017

2-chloro-2'-deoxyadenosine in the treatment of Sjögren's syndrome-associated B cell lymphoproliferation (English)

1 reference

30 November 2017

Haralampos Moutsopoulos

series ordinal

3

object named as

Haralampos M Moutsopoulos

1 reference

30 November 2017

Michalis Voulgarelis

1

1 reference

PubMed ID

12209533

30 November 2017

George Petroutsos

series ordinal

2

1 reference

PubMed ID

12209533

30 November 2017

Fotini N Skopouli

series ordinal

4

1 reference

30 November 2017

1 August 2002

1 reference

30 November 2017

Arthritis & Rheumatology

1 reference

30 November 2017

46

1 reference

30 November 2017

8

1 reference

30 November 2017

2248-2249

1 reference

Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome

30 November 2017

1 reference

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome

21 January 2018

1 reference

2-Chlorodeoxyadenosine: a newer purine analog active in the treatment of indolent lymphoid malignancies

21 January 2018

1 reference

A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.10434

1 reference

30 November 2017

1 reference

PubMed ID

12209533